Use of tociluzumab in the thrombocytopenic COVID-19 patient: A challenge in the therapeutic approach

Catégorie d'article: Letter to Editor

Publié en ligne: 29 déc. 2022

Pages: 89 - 90

DOI: https://doi.org/10.2478/rjaic-2021-0015

Mots clés

© 2021 Ozlem Ozkan Kuscu and Pinar Ergenoglu, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.